{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T10:34:24Z","timestamp":1722162864770},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/ico.0b013e318033a6f2","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T14:32:33Z","timestamp":1473258753000},"page":"585-588","source":"Crossref","is-referenced-by-count":11,"title":["Zymar (Gatifloxacin 0.3%) Shows Excellent Gram-Negative Activity Against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White Rabbit Keratitis Model"],"prefix":"10.1097","volume":"26","author":[{"given":"Francis S","family":"Mah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric G","family":"Romanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regis P","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y Jerold","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0161-6420(97)30326-1","article-title":"The endophthalmitis vitrectomy study. Relationship between clinical presentation and microbiologic spectrum.","volume":"104","author":"Johnson","year":"1997","journal-title":"Ophthalmology"},{"key":"R2-15-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0161-6420(87)33491-8","article-title":"Corneal ulcers associated with cosmetic extended wear soft contact lenses.","volume":"94","author":"Cohen","year":"1987","journal-title":"Ophthalmology"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0161-6420(01)00724-2","article-title":"An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa keratitis.","volume":"108","author":"Kowalski","year":"2001","journal-title":"Ophthalmology"},{"key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajo.2004.03.016","article-title":"A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.","volume":"138","author":"Rhee","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/jop.2005.21.36","article-title":"Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.","volume":"21","author":"Jensen","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.","volume":"113","author":"OBrien","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"R9-15-20210204","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","article-title":"Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.","volume":"106","author":"Goldstein","year":"1999","journal-title":"Ophthalmology"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":"An ophthalmologists guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.","volume":"112","author":"Kowalski","year":"2005","journal-title":"Ophthalmology"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R12-15-20210204","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":"The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (Gatifloxacin 0.3%) in a NZW Rabbit Model.","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1076\/ceyr.28.5.337.28676","article-title":"Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.","volume":"28","author":"Thibodeaux","year":"2004","journal-title":"Curr Eye Res"},{"key":"R14-15-20210204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3181\/00379727-45-11807P","article-title":"Sulfapyridine in experimental pyocyaneus infection of the cornea.","volume":"45","author":"Joy","year":"1940","journal-title":"Proc Soc Exp Biol Med"},{"key":"R15-15-20210204","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/148167a0","article-title":"Local treatment of experimental pyocyaneus ulcer of the cornea with albucid soluble.","volume":"148","author":"Robson","year":"1941","journal-title":"Nature"},{"key":"R16-15-20210204","first-page":"3017","article-title":"Topical antibiotic therapy for the treatment of experimental Staphylococcal aureus keratitis.","volume":"33","author":"Callegan","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-15-20210204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00003226-199203000-00008","article-title":"Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.","volume":"11","author":"Gritz","year":"1992","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318033a6f2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:27:29Z","timestamp":1621884449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200706000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318033a6f2","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}